SOLACI-SOCIME 2022 | Mitral valve replacement

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress.

In this case, consult the presentation by Dr. Ignacio Amat Santos, entitled “Mitral valve replacement”


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-SOCIME 2022 | Big Necks, (PEVAR IN HOSTILE NECK) – Dr. Juan Varela

Veja esta apresentação do Dr. Juan Varela (COL) durante o Congresso SOLACI-SOCIME 2022 realizado na Expo Santa Fé, CDMX nos dias 4, 5 e...

SOLACI-SOCIME 2022 | Advances in the design of STENTS in PCI: DIABETES MELLITUS – Dr. Roxana Mehran

Enjoy this master conference given by Dr. Roxana Mehran during the SOLACI-SOCIME 2022 Congress held at Expo Santa Fé, CDMX on August 4, 5...

SOLACI-SOCIME 2022 | Management of entrapped equipment, by Dr. José Velazco

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. José Velazco, entitled...

SOLACI-SOCIME 2022 | Transcatheter treatment of mitral valve regurgitation, by Dr. Luis Nombela Franco

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Luis Nombela Franco,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...